4.6 Article

Polymersome nanoparticles for delivery of Wnt-activating small molecules

Journal

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 14, Issue 4, Pages 1267-1277

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2018.02.014

Keywords

Polymersomes; Wnt; Drug delivery

Funding

  1. Medical Research Council, United Kingdom [MR/J004103/1]
  2. Wessex Medical Research, UoS Research Management Committee, Nanoear FP6 [FP-6 NMP4-CT-2006]
  3. Malaya University, Malaysia
  4. Institute for Life Sciences, Southampton, U.K.

Ask authors/readers for more resources

Spatiotemporal control of drug delivery is important for a number of medical applications and may be achieved using polymersome nanoparticles (PMs). Wnt signalling is a molecular pathway activated in various physiological processes, including bone repair, that requires precise control of activation. Here, we hypothesise that PMs can be stably loaded with a small molecule Wnt agonist, 6-bromoindirubin-3'-oxime (BIO), and activate Wnt signalling promoting the osteogenic differentiation in human primary bone marrow stromal cells (BMSCs). We showed that BIO-PMs induced a 40% increase in Wnt signaling activation in reporter cell lines without cytotoxicity induced by free BIO. BMSCs incubated with BIO-PMs showed a significant up-regulation of the Wnt target gene AXIN2 (14 +/- 4 fold increase, P < 0.001) and a prolonged activation of the osteogenic gene RUNX2. We conclude that BIO-PMs could represent an innovative approach for the controlled activation of Wnt signaling for promoting bone regeneration after fracture. (C) 2018 The Authors. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available